Sources

11 Total Sources

Apogee Soars 47% After AbbVie Offers $10.9 Billion in Cash

Left25%

Center75%

The Motley Fool63d ago

AbbVie Offers $10.9 Billion Cash for Apogee Therapeutics; Stock Soars

Yahoo Finance63d ago

AbbVie's biggest deal since 2019 could land soon

Yahoo Finance63d ago

AbbVie strikes $10.9 billion deal for Apogee Therapeutics

pharmaphorum63d ago

AbbVie climbs post-Allergan M&A peak with Apogee buy | pharmaphorum

Finimize63d ago

AbbVie Nears $10.9 Billion Deal For Apogee Therapeutics - Finimize

AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Immunology Deal | citybiz

AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio " AbbVie (NYSE: $ABBV) and Apogee Therapeutics (NASDAQ: $APGE) ("Apogee") today announced they have entered into a definitive agreement under which AbbVie will acquire Apogee

streamlinefeed.co.ke62d ago

AbbVie Buys Apogee for $10.9 Billion to Acquire Inflammatory Disease Drug Pipeline | Streamline

AbbVie to Acquire Apogee Therapeutics for $10.9 Billion, Deepening Immunology Portfolio

Marketscreener.com63d ago

AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio | MarketScreener

advfn.com63d ago

APGE - AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio